Holen Sie sich die Stockscreener-App
9.55
0.10%
0.01
Handel nachbörslich:
9.70
0.15
+1.57%
Schlusskurs vom Vortag:
$9.54
Offen:
$9.5
24-Stunden-Volumen:
1.58M
Relative Volume:
0.98
Marktkapitalisierung:
$3.00B
Einnahmen:
$2.68B
Nettoeinkommen (Verlust:
$-184.45M
KGV:
-14.03
EPS:
-0.6805
Netto-Cashflow:
$229.23M
1W Leistung:
+0.00%
1M Leistung:
+19.97%
6M Leistung:
+8.03%
1J Leistung:
+12.49%
1-Tages-Spanne:
$9.32
$9.61
1-Wochen-Bereich:
$9.32
$9.76
52-Wochen-Spanne:
$6.685
$9.79
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
Firmenname
Amneal Pharmaceuticals Inc
Sektor
Telefon
908-947-3120
Adresse
400 Crossing Boulevard, 3rd Floor, Bridgewater
Vergleichen Sie AMRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
9.55 | 3.01B | 2.68B | -184.45M | 229.23M | -0.6805 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-06 | Eingeleitet | Goldman | Buy |
| 2025-02-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | Hochstufung | Goldman | Sell → Buy |
| 2020-12-14 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-12-14 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-27 | Eingeleitet | Goldman | Sell |
| 2020-05-12 | Hochstufung | Guggenheim | Sell → Neutral |
| 2019-12-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-11-07 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | Eingeleitet | Barclays | Equal Weight |
| 2019-05-21 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-03-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | Herabstufung | SunTrust | Buy → Hold |
| 2018-08-13 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-06-22 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Alle ansehen
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
Can machine learning forecast Amneal Pharmaceuticals Inc. recoveryMarket Activity Summary & Breakout Confirmation Alerts - Newser
Amneal Pharmaceuticals Inc. stock trend forecast2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Is it too late to sell Amneal Pharmaceuticals Inc.2025 Winners & Losers & Daily Growth Stock Investment Tips - Newser
How hedge fund analytics apply to Amneal Pharmaceuticals Inc. stockWeekly Trading Summary & AI Enhanced Trading Signals - Newser
What are the risks of holding Amneal Pharmaceuticals Inc.2025 Geopolitical Influence & Advanced Technical Signal Analysis - khodrobank.com
Is Amneal Pharmaceuticals Inc.’s ROE strong enoughQuarterly Trade Review & Capital Efficiency Focused Strategies - khodrobank.com
Amneal Pharmaceuticals Inc. stock daily chart insightsQuarterly Earnings Summary & Fast Momentum Entry Tips - Newser
What makes Amneal Pharmaceuticals Inc. stock attractive todayPortfolio Return Report & AI Powered Buy and Sell Recommendations - khodrobank.com
Regression analysis insights on Amneal Pharmaceuticals Inc. performanceJuly 2025 Closing Moves & Weekly Chart Analysis and Guides - Newser
Detecting price anomalies in Amneal Pharmaceuticals Inc. with AI2025 Support & Resistance & Advanced Technical Signal Analysis - Newser
Does Amneal Pharmaceuticals Inc. qualify in momentum factor screeningPortfolio Risk Report & Real-Time Volume Spike Alerts - Newser
Published on: 2025-09-03 02:26:05 - Newser
Should you wait for a breakout in Amneal Pharmaceuticals Inc.Quarterly Risk Review & Free Real-Time Market Sentiment Alerts - Newser
Comparing Amneal Pharmaceuticals Inc. in custom built stock radarsGlobal Markets & Long-Term Safe Investment Plans - Newser
Is Amneal Pharmaceuticals Inc. building a consolidation basePortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
Is Amneal Pharmaceuticals Inc. forming a bullish divergenceTrade Exit Report & Long-Term Growth Plans - khodrobank.com
Tools to monitor Amneal Pharmaceuticals Inc. recovery probability2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - Newser
Published on: 2025-09-02 10:39:09 - Newser
Is Amneal Pharmaceuticals Inc. stock showing strong momentum2025 Technical Overview & Real-Time Buy Zone Alerts - khodrobank.com
Analyzing net buyer seller activity in Amneal Pharmaceuticals Inc.Exit Point & Reliable Price Breakout Alerts - Newser
Is Amneal Pharmaceuticals Inc. stock undervalued right nowInsider Buying & Risk Adjusted Buy/Sell Alerts - khodrobank.com
Why Amneal Pharmaceuticals Inc. is moving todayRisk Management & Verified Technical Signals - Newser
Is Amneal Pharmaceuticals Inc. being accumulated by smart moneyPrice Action & AI Driven Stock Reports - khodrobank.com
Using data models to predict Amneal Pharmaceuticals Inc. stock movementTake Profit & Intraday High Probability Setup Alerts - Newser
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet - sharewise.com
Fundamentals Check: Is Amneal Pharmaceuticals Inc. a strong growth stockJuly 2025 Fed Impact & Reliable Volume Spike Trade Alerts - khodrobank.com
How to forecast Amneal Pharmaceuticals Inc. trends using time seriesEarnings Beat & Stock Portfolio Risk Control - Newser
Amneal Pharmaceuticals Inc. Approaches Support With Recovery in Sight getLinesFromResByArray error: size == 0 - kangso.co.kr
Key resistance and support levels for Amneal Pharmaceuticals Inc.Dollar Strength & High Conviction Investment Ideas - Newser
Amneal Pharmaceuticals Inc. Stock Recovery Path — Analyst Breakdown2025 Market Outlook & Risk Controlled Daily Plans - beatles.ru
Can a trend reversal in Amneal Pharmaceuticals Inc. lead to recoveryRate Cut & Long-Term Capital Growth Strategies - Newser
Using data tools to time your Amneal Pharmaceuticals Inc. exitJuly 2025 Trends & Consistent Profit Trade Alerts - Newser
Building trade automation scripts for Amneal Pharmaceuticals Inc.Portfolio Update Summary & High Conviction Buy Zone Alerts - Newser
What technical models suggest about Amneal Pharmaceuticals Inc.’s comeback2025 Fundamental Recap & Reliable Price Breakout Alerts - Newser
Is Amneal Pharmaceuticals Inc. forming a bottoming baseWeekly Profit Recap & Verified Technical Trade Signals - Newser
Has Amneal Pharmaceuticals Inc. formed a bullish divergenceWeekly Profit Summary & Verified Entry Point Detection - Newser
Finanzdaten der Amneal Pharmaceuticals Inc-Aktie (AMRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):